Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
- PMID: 14625564
- DOI: 10.1038/sj.gt.3302133
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
Abstract
Adeno-associated virus (AAV) is a promising gene vector based on a single-stranded (ss) DNA virus. Its transgene expression requires the conversion of ssDNA to double-stranded (ds) genome, a slow process responsible for the delayed transduction and occasional inefficiency. By mutating the inverted terminal repeat, we have made novel AAV vectors that predominantly package the self-complementary dsDNA genome. The dsAAV consistently demonstrated superior and accelerated transduction in vitro and in vivo. Dramatic increases in transgene expression were observed in most of the cell lines examined, including B16 melanoma and 3LL lung cancer that are difficult to be transduced by the conventional ssAAV vectors. Similar increases were also observed in vivo in a variety of tissues including muscle and liver. The dsAAV transduced a vast majority of the hepatocytes for more than 6 months, while the ssAAV transduced only a small fraction. In addition to circumventing the requirement for DNA synthesis, the dsAAV exhibited higher in vivo DNA stability and more effective circularization than the ssAAV, suggesting potential molecular mechanisms for the faster, stronger and prolonged transgene expression.
Similar articles
-
Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.Gene Ther. 2008 Sep;15(18):1287-93. doi: 10.1038/gt.2008.89. Epub 2008 May 22. Gene Ther. 2008. PMID: 18496572
-
Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.Mol Ther. 2004 Nov;10(5):950-7. doi: 10.1016/j.ymthe.2004.07.018. Mol Ther. 2004. PMID: 15509512
-
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.Gene Ther. 2003 Dec;10(26):2112-8. doi: 10.1038/sj.gt.3302134. Gene Ther. 2003. PMID: 14625565
-
[Trends in development of self-complementary adeno-associated virus vector].Sheng Wu Gong Cheng Xue Bao. 2009 May;25(5):658-64. Sheng Wu Gong Cheng Xue Bao. 2009. PMID: 19670632 Review. Chinese.
-
Self-complementary AAV vectors; advances and applications.Mol Ther. 2008 Oct;16(10):1648-56. doi: 10.1038/mt.2008.171. Epub 2008 Aug 5. Mol Ther. 2008. PMID: 18682697 Review.
Cited by
-
Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia.J Genet Syndr Gene Ther. 2012 Jan 18;1:1-9. doi: 10.4172/2157-7412.S1-009. J Genet Syndr Gene Ther. 2012. PMID: 23565343 Free PMC article.
-
Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses.Hum Gene Ther Methods. 2016 Aug;27(4):143-9. doi: 10.1089/hgtb.2016.054. Hum Gene Ther Methods. 2016. PMID: 27431826 Free PMC article.
-
Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsin.Mol Ther. 2010 Aug;18(8):1553-8. doi: 10.1038/mt.2010.116. Epub 2010 Jun 15. Mol Ther. 2010. PMID: 20551917 Free PMC article.
-
Down-regulation of expression of rat pyruvate dehydrogenase E1alpha gene by self-complementary adeno-associated virus-mediated small interfering RNA delivery.Mitochondrion. 2007 Jul;7(4):253-9. doi: 10.1016/j.mito.2007.02.003. Epub 2007 Feb 20. Mitochondrion. 2007. PMID: 17392036 Free PMC article.
-
Viral Delivery Systems for CRISPR.Viruses. 2019 Jan 4;11(1):28. doi: 10.3390/v11010028. Viruses. 2019. PMID: 30621179 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources